Zhong Guo Xin Wen Wang·2025-09-27 01:26Core Insights - The 15th China Henan International Investment and Trade Fair is currently taking place in Zhengzhou, focusing on new opportunities in the biopharmaceutical industry [1] - The Innovation Drug and Modern Pharmaceutical Industry Cooperation Exchange Conference is a key event, gathering over a hundred representatives from renowned pharmaceutical companies and medical institutions [1] Group 1: Investment Attraction - Companies are drawn to the Zhengzhou Airport Economic Comprehensive Experimental Zone due to its fast approval processes, efficient services, and favorable conditions [3] - Notable investments include the 2.5 billion yuan "Medical City Star Future Fund" by Fosun Pharma and the entry of BD Medical, a global medical device giant, marking the first biopharmaceutical manufacturing project from a Fortune 500 company in the region [3] - The region's appeal is bolstered by its rich clinical resources, improving research capabilities, and an increasingly attractive policy environment for multinational medical enterprises [3] Group 2: Regional Advantages - The Zhengzhou Airport Zone has established a "six-dimensional advantage" framework, which includes national strategic support, transportation hub benefits, a large population market, top-tier medical resources, efficient administrative approvals, and high-quality living conditions [3] - The local drug regulatory authority provides streamlined evaluation services, enhancing operational and innovation efficiency for enterprises [3] Group 3: Policy Support - The conference served as a platform for dialogue, with officials from the Henan Provincial Health Commission, Medical Insurance Bureau, and Drug Administration present to discuss supportive measures for industry development [4] - The Henan Medical Insurance Bureau has implemented a "dual-channel" mechanism for specific outpatient drugs and optimized drug listing processes, resulting in over 4 billion yuan in additional compensation for cases using new drugs and technologies [5] - The goal is to achieve a win-win situation where patients benefit, companies grow, and the fund remains sustainable [5]